FindTrial
Sign In

The role of active stimulation in patients that have benefited from the long-term effects of MCS in the treatment of orofacial pain

The role of active stimulation in patients that have benefited from the long-term effects of MCS in the treatment of orofacial pain - The role of active stimulation of MCS

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON45382
Enrollment
12
Registered
2017-09-19
Start date
Unknown
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Trigeminal neuropathy

Interventions

Motor Cortex Stimulation
Orofacial Pain

Sponsors

Radboud Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: For this study, we aim to include 12 patients that have undergone MCS for treating chronic orofacial pain. All patients have responded favourable to MCS (at least 40% pain reduction) and had at baseline a NRS > 5 (0= no pain, 10= worst possible pain). All patients underwent insertion of electrodes for MCS for chronic neuropathic pain between 2005 and 2012.

Exclusion criteria

Exclusion criteria: Patients who underwent the insertion of the MCS system after 2012 were excluded. Also, patients that showed an inadequate response to MCS (

Design outcomes

Primary

MeasureTime frame
Pain scores, pain dimensions, Quality of Life, daily intake of pain medication with use of the McGill Pain Questionnaire (Dutch Version) and qualitative exploration of their experiences with use of interviews.—

Secondary

MeasureTime frame
-—

Countries

The Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)